217 related articles for article (PubMed ID: 25329549)
1. Exploring the anti-cancer activity of novel thiosemicarbazones generated through the combination of retro-fragments: dissection of critical structure-activity relationships.
Serda M; Kalinowski DS; Rasko N; Potůčková E; Mrozek-Wilczkiewicz A; Musiol R; Małecki JG; Sajewicz M; Ratuszna A; Muchowicz A; Gołąb J; Simůnek T; Richardson DR; Polanski J
PLoS One; 2014; 9(10):e110291. PubMed ID: 25329549
[TBL] [Abstract][Full Text] [Related]
2. Piperazinyl fragment improves anticancer activity of Triapine.
Rejmund M; Mrozek-Wilczkiewicz A; Malarz K; Pyrkosz-Bulska M; Gajcy K; Sajewicz M; Musiol R; Polanski J
PLoS One; 2018; 13(4):e0188767. PubMed ID: 29652894
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity studies of 4-phenyl-substituted 2'-benzoylpyridine thiosemicarbazones with potent and selective anti-tumour activity.
Lukmantara AY; Kalinowski DS; Kumar N; Richardson DR
Org Biomol Chem; 2013 Oct; 11(37):6414-25. PubMed ID: 23963445
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity.
Opletalová V; Kalinowski DS; Vejsová M; Kunes J; Pour M; Jampílek J; Buchta V; Richardson DR
Chem Res Toxicol; 2008 Sep; 21(9):1878-89. PubMed ID: 18698850
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analogues.
Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
J Med Chem; 2007 Nov; 50(24):6212-25. PubMed ID: 17963372
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents.
Kalinowski DS; Yu Y; Sharpe PC; Islam M; Liao YT; Lovejoy DB; Kumar N; Bernhardt PV; Richardson DR
J Med Chem; 2007 Jul; 50(15):3716-29. PubMed ID: 17602603
[TBL] [Abstract][Full Text] [Related]
7. Halogenated 2'-benzoylpyridine thiosemicarbazone (XBpT) chelators with potent and selective anti-neoplastic activity: relationship to intracellular redox activity.
Stefani C; Punnia-Moorthy G; Lovejoy DB; Jansson PJ; Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
J Med Chem; 2011 Oct; 54(19):6936-48. PubMed ID: 21846118
[TBL] [Abstract][Full Text] [Related]
8. Alkyl substituted 2'-benzoylpyridine thiosemicarbazone chelators with potent and selective anti-neoplastic activity: novel ligands that limit methemoglobin formation.
Stefani C; Jansson PJ; Gutierrez E; Bernhardt PV; Richardson DR; Kalinowski DS
J Med Chem; 2013 Jan; 56(1):357-70. PubMed ID: 23276209
[TBL] [Abstract][Full Text] [Related]
9. N
Sólimo A; Soraires Santacruz MC; Loaiza Perez AI; Bal de Kier Joffé E; Finkielsztein LM; Callero MA
J Cell Physiol; 2018 Jun; 233(6):4677-4687. PubMed ID: 29111571
[TBL] [Abstract][Full Text] [Related]
10. High Copper Complex Stability and Slow Reduction Kinetics as Key Parameters for Improved Activity, Paraptosis Induction, and Impact on Drug-Resistant Cells of Anticancer Thiosemicarbazones.
Hager S; Pape VFS; Pósa V; Montsch B; Uhlik L; Szakács G; Tóth S; Jabronka N; Keppler BK; Kowol CR; Enyedy ÉA; Heffeter P
Antioxid Redox Signal; 2020 Aug; 33(6):395-414. PubMed ID: 32336116
[No Abstract] [Full Text] [Related]
11. 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.
Richardson DR; Kalinowski DS; Richardson V; Sharpe PC; Lovejoy DB; Islam M; Bernhardt PV
J Med Chem; 2009 Mar; 52(5):1459-70. PubMed ID: 19216562
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 2-benzoylpyridine thiosemicarbazones in a dimeric system: structure-activity relationship studies on their anti-proliferative and iron chelation efficacy.
Lukmantara AY; Kalinowski DS; Kumar N; Richardson DR
J Inorg Biochem; 2014 Dec; 141():43-54. PubMed ID: 25217717
[TBL] [Abstract][Full Text] [Related]
13. Thiosemicarbazones as Potent Anticancer Agents and their Modes of Action.
Shakya B; Yadav PN
Mini Rev Med Chem; 2020; 20(8):638-661. PubMed ID: 31660812
[TBL] [Abstract][Full Text] [Related]
14. Novel "hybrid" iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective antiproliferative activity against tumor cells.
Lovejoy DB; Richardson DR
Blood; 2002 Jul; 100(2):666-76. PubMed ID: 12091363
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of quinoline-based thiosemicarbazones and correlation of cellular iron-binding efficacy to anti-tumor efficacy.
Serda M; Kalinowski DS; Mrozek-Wilczkiewicz A; Musiol R; Szurko A; Ratuszna A; Pantarat N; Kovacevic Z; Merlot AM; Richardson DR; Polanski J
Bioorg Med Chem Lett; 2012 Sep; 22(17):5527-31. PubMed ID: 22858101
[TBL] [Abstract][Full Text] [Related]
16. Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.
Jansson PJ; Sharpe PC; Bernhardt PV; Richardson DR
J Med Chem; 2010 Aug; 53(15):5759-69. PubMed ID: 20597487
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.
Potůčková E; Roh J; Macháček M; Sahni S; Stariat J; Šesták V; Jansová H; Hašková P; Jirkovská A; Vávrová K; Kovaříková P; Kalinowski DS; Richardson DR; Šimůnek T
PLoS One; 2015; 10(10):e0139929. PubMed ID: 26460540
[TBL] [Abstract][Full Text] [Related]
18. Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo.
Lovejoy DB; Sharp DM; Seebacher N; Obeidy P; Prichard T; Stefani C; Basha MT; Sharpe PC; Jansson PJ; Kalinowski DS; Bernhardt PV; Richardson DR
J Med Chem; 2012 Aug; 55(16):7230-44. PubMed ID: 22861499
[TBL] [Abstract][Full Text] [Related]
19. Anticancer activity of the thiosemicarbazones that are based on di-2-pyridine ketone and quinoline moiety.
Mrozek-Wilczkiewicz A; Malarz K; Rejmund M; Polanski J; Musiol R
Eur J Med Chem; 2019 Jun; 171():180-194. PubMed ID: 30921758
[TBL] [Abstract][Full Text] [Related]
20. Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity.
Richardson DR; Sharpe PC; Lovejoy DB; Senaratne D; Kalinowski DS; Islam M; Bernhardt PV
J Med Chem; 2006 Nov; 49(22):6510-21. PubMed ID: 17064069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
